Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark Pusung
Preexisting Oncogenic Events Impact Trastuzumab Sensitivity in ERBB2-amplified Gastroesophageal Adenocarcinoma
Journal of Clinical Investigation
Medicine
Related publications
Advanced Lung Adenocarcinoma Patient With ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits From Trastuzumab
Case Reports in Oncological Medicine
Oncology
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Cooperative but Distinct Early Co-Signaling Events Originate From ERBB2 and ERBB1 Receptors Upon Trastuzumab Treatment in Breast Cancer Cells
Oncotarget
Oncology
Strong EGFR Signaling in Cell Line Models of ERBB2-amplified Breast Cancer Attenuates Response Towards ERBB2-targeting Drugs
Oncogenesis
Cancer Research
Molecular Biology
A Multicenter Phase 2 Study of AMG 337 in Patients With MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
The Focally Amplified lncRNA FAL1 Exhibits Oncogenic Activity
Cancer Discovery
Oncology
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer
JAMA Oncology
Cancer Research
Oncology
Two Novel Human Anti-ErbB2 Immunoagents Are Active on Trastuzumab-Resistant Tumours
British Journal of Cancer
Cancer Research
Oncology
Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-Junction Adenocarcinoma After Pembrolizumab
Cureus
